SCHEMBL3178301

SCHEMBL3178301

O=C(O)CN1CC(O)CC1=O

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.70
BLM P54132 1/20 0.70
ACE P12821 3/20 0.40
POLB P06746 2/20 0.39
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
KMT2A Q03164 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 1/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3178292 1.00 APEX1 (0.70) APEX1BLMACEPOLBTP53
SCHEMBL19119195 1.00 APEX1 (0.70) APEX1BLMACEPOLBTP53
Oxiracetam SCHEMBL2322773 0.83 APEX1 (0.84) APEX1BLMPOLBTP53TSHR
Oxiracetam SCHEMBL15789330 0.82 APEX1 (1.00) APEX1BLMPOLBTP53TSHR
Oxiracetam SCHEMBL2596758 0.82 APEX1 (1.00) APEX1BLMPOLBTP53TSHR
SCHEMBL14426907 0.82 APEX1 (0.68) APEX1BLMPOLBTP53L3MBTL1
Oxiracetam SCHEMBL526050 0.82 APEX1 (1.00) APEX1BLMPOLBTP53TSHR
SCHEMBL10582437 0.81 APEX1 (0.57) APEX1BLMPOLBTP53TSHR
SCHEMBL7060207 0.81 APEX1 (0.52) APEX1BLMTP53L3MBTL1KMT2A
Oxiracetam SCHEMBL15789157 0.81 APEX1 (0.96) APEX1BLMPOLBTP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119219540-A Oxiracetam and key intermediate of optical isomer thereof, and preparation method and application thereof 成都百途医药科技有限公司 2024-12-31 CN claimed
CN-119192049-A Preparation method of oxiracetam impurity B 江苏诚信药业有限公司 2024-12-27 CN claimed
CN-112724062-B Preparation method of oxiracetam impurity B 江苏诚信药业有限公司 2022-03-15 CN claimed
CN-109748837-B Preparation method of 4-hydroxy-2-oxo-1-pyrrolidine acetamide 重庆医药高等专科学校 2021-07-09 CN claimed
CN-112745254-A Preparation method and application of 4-hydroxy-2-oxo-1-pyrrolidine acetic acid 江苏诚信药业有限公司 2021-05-04 CN claimed
EP-0847990-A1 4-(C1-C4)-Alkoxy-3-pyrrolin-2-on-1-yl-acetic acid derivatives, their preparation and use in the synthesis of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide LONZA AG (CH) 1998-06-17 EP claimed
US-5371237-A Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide LONZA LTD. (CH) 1994-12-06 US claimed
US-5276164-A Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide LONZA LTD. (CH) 1994-01-04 US claimed
EP-0538505-A1 Process for the preparation of 4-hydroxy-2-oxo-pyrrolidinyl-1-acetamide LONZA AG (CH) 1993-04-28 EP claimed
EP-0207681-B1 PYRROLIDONE DERIVATIVES ISF SOCIETA PER AZIONI (IT) 1992-03-18 EP claimed
US-4824966-A Process for the production of 4-hydroxy-2-oxo-pyrrolidin-1-yl acetamide LONZA LTD. (CH) 1989-04-25 US claimed
JP-5112525-A None JP disclosed
CN-119219540-A Oxiracetam and key intermediate of optical isomer thereof, and preparation method and application thereof 成都百途医药科技有限公司 2024-12-31 CN disclosed
CN-119192049-A Preparation method of oxiracetam impurity B 江苏诚信药业有限公司 2024-12-27 CN disclosed
CN-119192049-A Preparation method of oxiracetam impurity B 江苏诚信药业有限公司 2024-12-27 CN disclosed
US-4788212-A Pyrrolidin-2-one derivatives having nootropic activity GIBIPHARMA S.P.A. (IT) 1988-11-29 US disclosed
US-4703054-A Nootropic imidazolidinones ISF, S.P.A. (IT) 1987-10-27 US disclosed
EP-0207680-A2 Chemical compounds ISF SOCIETA PER AZIONI (IT) 1987-01-07 EP disclosed
EP-0207681-A2 Pyrrolidone derivatives ISF SOCIETA PER AZIONI (IT) 1987-01-07 EP disclosed
US-4173569-A Preparation of pyrrolidine and pyrrolidin-2-one derivatives I.S.F. SPA (IT) 1979-11-06 US disclosed